Nabeel Sarhill is an Oncology physician affiliated with Texas State Technical College Harlingen. OpenAlex indexes 26 publications with 1,031 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2121 Pease St Ste 101
Harlingen, TX 785508321
Telephone
956-425-8845Registry record last updated 21 Feb 2013.
Industry payments
46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20251 payment
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- Daiichi Sankyo Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
66.8%Parenteral Iron Replacement54%Iron sucrose100%Part B, office-administered≥28 patientsErythropoiesis-stimulating Agent10%Darbepoetin alfa100%Part B, office-administered≥12 patients+ 3 more classes in this area
Metabolism & gastrointestinal
21.5%Other antiemetics18.4%Fosaprepitant100%Part B, office-administered≥18 patientsSerotonin-3 Receptor Antagonist2.8%Palonosetron hcl56%Granisetron hydrochloride29%Ondansetron Hcl11%Ondansetron Odt3%Part D + Part B≥68 patients+ 5 more classes in this area
Musculoskeletal
5.5%RANK Ligand Inhibitor5.1%Denosumab100%Part B, office-administered≥23 patientsBisphosphonate0.3%Zoledronic acid100%Part B, office-administered≥21 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S2734 Hodgkin’s Lymphoma in a Patient With Ulcerative Colitis: Case Presentation
The American Journal of Gastroenterology
2022 - Doxycycline Didn’t Cure the Fever! An Interesting Case of Large Granular Lymphocytic (LGL) Leukemia with Secondary Hemophagocytic Lymphohistiocytosis (HLH).
ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley)
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”